Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus

Tools
- Tools
+ Tools

Khunti, Kamlesh, Stone, Margaret A., Burden, Andrew C., Turner, David, Raymond, Neil T., Burden, Mary and Baker, Richard. (2006) Randomised controlled trial of near-patient testing for glycated haemoglobin in people with type 2 diabetes mellitus. BRITISH JOURNAL OF GENERAL PRACTICE, 56 (528). pp. 511-517. ISSN 0960-1643

Full text not available from this repository.

Abstract

Background Tight glycaemic control in people with type 2 diabetes can lead to a reduction in microvascular and possibly macrovascular complications. The use of near-patient (rapid) testing offers a potential method to improve glycaemic control. Aim To assess the effect and costs of rapid testing for glycated haemoglobin (HbA1c) in people with type 2 diabetes. Design of study Pragmatic open randomised controlled trial. Setting Eight practices in Leicestershire, UK. Method Patients were randomised to receive instant results for HbA1c or to routine care. The principal outcome measure was the proportion of patients with an HbA1c <7% at 12 months. We also assessed costs for the two groups. Results Of the 681 patients recruited to the study 638 (94%) were included in the analysis. The mean age at baseline was 65.7 years (SD = 10.8 years) with a median (interquartile range) duration of diabetes of 4 (1-8) years. The proportion of patients with HbA1c <7% did not differ significantly between the intervention and control groups (37 versus 38%, odds ratio 0.95 [95% confidence interval = 0.69 to 1.31]) at 12 months follow up. The total cost for diabetes-related care was 2390 per patient for the control group and 2370 for the intervention group. This difference was not statistically significant. Conclusion Near-patient testing for HbA1c alone does not lead to outcome or cost benefits in managing people with type 2 diabetes in primary care. Further research is required into the use of rapid testing as part of an optimised patient management model including arrangements for patient review and testing.

Item Type: Journal Article
Subjects: R Medicine
Journal or Publication Title: BRITISH JOURNAL OF GENERAL PRACTICE
Publisher: ROYAL COLL GENERAL PRACTITIONERS
ISSN: 0960-1643
Date: July 2006
Volume: 56
Number: 528
Number of Pages: 7
Page Range: pp. 511-517
Publication Status: Published
URI: http://wrap.warwick.ac.uk/id/eprint/33223

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us